Moheb Afzali , F. (2026) “BCc1, a Chelation-Based Nanomedicine, modulates splenic cytokine networks toward a profile associated with antitumor immunity in 4T1 breast tumor–bearing mice”, Archives of Advances in Biosciences, 17(1), pp. 1–13. doi: 10.22037/aab.v16i1.52004.